奥拉生物科技 AURA
$6.56 +$0.22 (+3.47%)
休市 · Nov 6, 8:10 pm ET · 最新盘后价 $6.56 0.00%
开盘$6.35
昨收$6.34
当日区间$6.17 – $6.66
成交量859.0K
市值$680.30M
市盈率(TTM)–
股息率–
股权结构与仓位
谁在持有、谁在做空,以及大资金的流向
机构持股比例94.9%+1.43 个百分点,较上季度
持仓机构数182+2 ,较上季度
内部人近期交易35次买入 / 15次卖出净买入
空头持仓比例10.50% 占流通股回补天数 10.6 · 截至 15 Oct 2026
卖空成交量占比26.9%近5日成交量平均占比
卖空成交量占当日成交量比例
大单净流入,近20个交易日
大单买入减卖出的净额(美元)。该窗口期内:+$204.7K(11个净流入日,9个净流出日)。
按单量净流入,近20个交易日
超大单/大单近似机构级别交易;中单/小单近似散户级别交易。各档买入减卖出净额,按窗口期累计。
已披露的前五大股东合计持有31.9%的流通股。
最大股东
按投资者类型
过去6次双周报告中(31 Jul 2026至15 Oct 2026),空头持仓占流通股比例已从6.15%升至10.50%。
近期机构持仓变动
| 股东 | 类型 | 期间 | 持股变动 | 新持股比例 |
|---|---|---|---|---|
| Forbion Capital Partners B.V. | VC/PE Fund | 2026/Q3 | +1,195,066 | 5.1% |
| TCG Crossover Management, LLC | VC/PE Fund | 2026/Q3 | +9,533,333 | 9.2% |
| Caligan Partners, LP | Hedge Fund | 2026/Q3 | +4,068,384 | 4.1% |
| OrbiMed Advisors LLC | VC/PE Fund | 2026/Q3 | +3,333,333 | 3.2% |
| Montanova Capital, LLC | Hedge Fund | 2026/Q3 | +2,833,333 | 6.9% |
| RA Capital Management, L.P. | VC/PE Fund | 2026/Q3 | +2,500,000 | 2.4% |
| Janus Henderson Group plc | Mutual Fund | 2026/Q3 | +2,500,000 | 2.4% |
| Vanguard Capital Management, LLC | Mutual Fund | 2026/Q3 | +2,096,558 | 4.6% |
| Balyasny Asset Management L.P. | Hedge Fund | 2026/Q3 | +1,796,965 | 2.3% |
| Redmile Group, LLC | Hedge Fund | 2026/Q3 | +1,666,667 | 1.6% |
| EcoR1 Capital, LLC | Hedge Fund | 2026/Q3 | +1,666,667 | 1.6% |
| Trails Edge Capital Partners, LP | Hedge Fund | 2026/Q3 | +1,443,333 | 1.4% |
| Foresite Capital Management, LLC | VC/PE Fund | 2026/Q3 | +1,333,334 | 1.3% |
| Woodline Partners LP | Hedge Fund | 2026/Q3 | +1,210,183 | 1.2% |
| Bellevue Asset Management AG | Mutual Fund | 2026/Q3 | +1,166,667 | 1.1% |
按报告期列出的机构买卖动态,变动幅度从大到小排列。
内部人交易
| 日期 | 内部人 | 职位 | 交易类型 | 股数 | 价格 | 交易后持股 |
|---|---|---|---|---|---|---|
| 31 Aug 2026 | Julie Person | Chief Human Resources Officer | Other Acquisition | +107,611 | – | 107,611 |
| 31 Aug 2026 | Julie Person | Chief Human Resources Officer | Other Derivative Acquisition | +212,389 | $7.43 | 212,389 |
| 31 Aug 2026 | Erica Kratz | Chief Regulatory & Quality Officer | Other Acquisition | +100,885 | – | 100,885 |
| 31 Aug 2026 | Erica Kratz | Chief Regulatory & Quality Officer | Other Derivative Acquisition | +199,115 | $7.43 | 199,115 |
| 31 Aug 2026 | J. Hopkins | Chief Medical Officer & President of Research and Development | Other Acquisition | +58,850 | – | 60,050 |
| 31 Aug 2026 | J. Hopkins | Chief Medical Officer & President of Research and Development | Other Derivative Acquisition | +116,150 | $7.43 | 116,150 |
| 31 Aug 2026 | Amy Elazzouzi | Senior Vice President of Finance, Treasurer and Secretary | Other Acquisition | +23,540 | – | 143,600 |
| 31 Aug 2026 | Amy Elazzouzi | Senior Vice President of Finance, Treasurer and Secretary | Other Derivative Acquisition | +46,460 | $7.43 | 46,460 |
| 6 Jul 2026 | Jeremy Bender | Independent Director | Other Acquisition | +30,000 | – | 30,000 |
| 6 Jul 2026 | Jeremy Bender | Independent Director | Other Derivative Acquisition | +60,000 | $7.03 | 60,000 |
| 30 Jun 2026 | Conor Kilroy | Former Chief Legal Officer | Other Acquisition | +14,858 | – | 193,053 |
| 15 Jun 2026 | Anthony Gibney | Former Chief Financial & Business Officer | Open Market Disposition | -12,824 | $6.42 | 81,609 |
| 10 Jun 2026 | Sapna Srivastava | Independent Director | Other Acquisition | +15,000 | – | 15,000 |
| 10 Jun 2026 | Sapna Srivastava | Independent Director | Other Derivative Acquisition | +30,000 | $6.21 | 30,000 |
| 10 Jun 2026 | Antony Mattessich | Independent Director | Other Acquisition | +15,000 | – | 15,000 |
| 10 Jun 2026 | Antony Mattessich | Independent Director | Other Derivative Acquisition | +30,000 | $6.21 | 30,000 |
| 10 Jun 2026 | David Johnson | Independent Chairperson | Other Acquisition | +15,000 | – | 15,000 |
| 10 Jun 2026 | David Johnson | Independent Chairperson | Other Derivative Acquisition | +30,000 | $6.21 | 30,000 |
| 10 Jun 2026 | Teresa Marie Bitetti | Director | Other Acquisition | +15,000 | – | 29,000 |
| 10 Jun 2026 | Teresa Marie Bitetti | Director | Other Derivative Acquisition | +30,000 | $6.21 | 30,000 |
数据来自Form 4/Form 144申报文件。负数为减持(出售、赠予或代扣税款股份),正数为增持。
空头持仓(按报告期)
| 报告日期 | 空头股数 | 占流通股比例 | 回补天数 |
|---|---|---|---|
| 15 Oct 2026 | 10,885,962 | 10.5% | 10.6 |
| 30 Sep 2026 | 10,366,122 | 10.0% | 9.2 |
| 15 Sep 2026 | 7,049,973 | 6.8% | 11.7 |
| 31 Aug 2026 | 6,203,498 | 6.0% | 6.4 |
| 14 Aug 2026 | 6,158,945 | 5.9% | 9.9 |
| 31 Jul 2026 | 6,358,049 | 6.1% | 18.5 |
暂无评论——快来第一个聊聊 AURA。
登录后参与讨论。